Applying Acylated Fucose Analogues to Metabolic Glycoengineering
AbstractManipulations of cell surface glycosylation or glycan decoration of selected proteins hold immense potential for exploring structure-activity relations or increasing glycoprotein quality. Metabolic glycoengineering describes the strategy where exogenously supplied sugar analogues intercept biosynthetic pathways and are incorporated into glycoconjugates. Low membrane permeability, which so far limited the large-scale adaption of this technology, can be addressed by the introduction of acylated monosaccharides. In this work, we investigated tetra-O-acetylated, -propanoylated and -polyethylene glycol (PEG)ylated fucoses. Concentrations of up to 500 µM had no substantial effects on viability and recombinant glycoprotein production of human embryonic kidney (HEK)-293T cells. Analogues applied to an engineered Chinese hamster ovary (CHO) cell line with blocked fucose de novo synthesis revealed an increase in cell surface and recombinant antibody fucosylation as proved by lectin blotting, mass spectrometry and monosaccharide analysis. Significant fucose incorporation was achieved for tetra-O-acetylated and -propanoylated fucoses already at 20 µM. Sequential fucosylation of the recombinant glycoprotein, achieved by the application of increasing concentrations of PEGylated fucose up to 70 µM, correlated with a reduced antibody’s binding activity in a Fcγ receptor IIIa (FcγRIIIa) binding assay. Our results provide further insights to modulate fucosylation by exploiting the salvage pathway via metabolic glycoengineering. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 1923 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Rosenlöcher, J.; Böhrsch, V.; Sacharjat, M.; Blanchard, V.; Giese, C.; Sandig, V.; Hackenberger, C.P.R.; Hinderlich, S. Applying Acylated Fucose Analogues to Metabolic Glycoengineering. Bioengineering 2015, 2, 213-234.
Rosenlöcher J, Böhrsch V, Sacharjat M, Blanchard V, Giese C, Sandig V, Hackenberger CPR, Hinderlich S. Applying Acylated Fucose Analogues to Metabolic Glycoengineering. Bioengineering. 2015; 2(4):213-234.Chicago/Turabian Style
Rosenlöcher, Julia; Böhrsch, Verena; Sacharjat, Michael; Blanchard, Véronique; Giese, Christoph; Sandig, Volker; Hackenberger, Christian P.R.; Hinderlich, Stephan. 2015. "Applying Acylated Fucose Analogues to Metabolic Glycoengineering." Bioengineering 2, no. 4: 213-234.